Instil Bio, Inc.TILNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+116.6%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+116.6%/yr
Quarterly compound
Percentile
P86
Within normal range
vs 3Y Ago
10.2x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 35.91% |
| Q2 2025 | 23.30% |
| Q1 2025 | -166.41% |
| Q4 2024 | 51.45% |
| Q3 2024 | -67.18% |
| Q2 2024 | 28.18% |
| Q1 2024 | -53.09% |
| Q4 2023 | 80.73% |
| Q3 2023 | -217.89% |
| Q2 2023 | 64.09% |
| Q1 2023 | -2.90% |
| Q4 2022 | -0.26% |
| Q3 2022 | 3.53% |
| Q2 2022 | -8.18% |
| Q1 2022 | -0.99% |
| Q4 2021 | -24.93% |
| Q3 2021 | -21.60% |
| Q2 2021 | -51.18% |
| Q1 2021 | -33.91% |
| Q4 2020 | -126.65% |
| Q3 2020 | -67.89% |
| Q2 2020 | -18.90% |
| Q1 2020 | 0.00% |